Yazici Y, McAlindon TE, Gibofsky A, et al. Radiographic outcomes from a randomized, double-blind, placebo-controlled, phase 2 study of a novel, intra-articular, injectable, WNT pathway inhibitor (SM04690) in the treatment of osteoarthritis of the knee: week 26 interim analysis. EULAR 2017, #OP0166.
Anti-C5a-antilichaam vilobelimab veilig bij ernstige COVID-19
feb 2021 | Pneumonie, Virale infecties